Global and United States PTCA Coronary Drug Eluting Balloons Market Insights, Forecast to 2027
SKU ID : QYR-18789403 | Publishing Date : 23-Jul-2021 | No. of pages : 131
Detailed TOC of Global and United States PTCA Coronary Drug Eluting Balloons Market Insights, Forecast to 2027
1 Study Coverage1.1 PTCA Coronary Drug Eluting Balloons Product Introduction
1.2 Market by Type
1.2.1 Global PTCA Coronary Drug Eluting Balloons Market Size Growth Rate by Type
1.2.2 DEB Balloon
1.2.3 Standard Balloon
1.3 Market by Application
1.3.1 Global PTCA Coronary Drug Eluting Balloons Market Size Growth Rate by Application
1.3.2 Small Vessel Disease
1.3.3 Bifurcation Lesions
1.3.4 Others
1.4 Study Objectives
1.5 Years Considered
2 Executive Summary
2.1 Global PTCA Coronary Drug Eluting Balloons Market Size, Estimates and Forecasts
2.1.1 Global PTCA Coronary Drug Eluting Balloons Revenue 2016-2027
2.1.2 Global PTCA Coronary Drug Eluting Balloons Sales 2016-2027
2.2 Global PTCA Coronary Drug Eluting Balloons, Market Size by Region: 2016 VS 2021 VS 2027
2.3 PTCA Coronary Drug Eluting Balloons Historical Market Size by Region (2016-2021)
2.3.1 Global PTCA Coronary Drug Eluting Balloons Retrospective Market Scenario in Sales by Region: 2016-2021
2.3.2 Global PTCA Coronary Drug Eluting Balloons Retrospective Market Scenario in Revenue by Region: 2016-2021
2.4 PTCA Coronary Drug Eluting Balloons Market Estimates and Projections by Region (2022-2027)
2.4.1 Global PTCA Coronary Drug Eluting Balloons Sales Forecast by Region (2022-2027)
2.4.2 Global PTCA Coronary Drug Eluting Balloons Revenue Forecast by Region (2022-2027)
3 Global PTCA Coronary Drug Eluting Balloons Competitor Landscape by Players
3.1 Global Top PTCA Coronary Drug Eluting Balloons Manufacturers by Sales
3.1.1 Global PTCA Coronary Drug Eluting Balloons Sales by Manufacturer (2016-2021)
3.1.2 Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Manufacturer (2016-2021)
3.2 Global Top PTCA Coronary Drug Eluting Balloons Manufacturers by Revenue
3.2.1 Key PTCA Coronary Drug Eluting Balloons Manufacturers Covered: Ranking by Revenue
3.2.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Manufacturers (2016-2021)
3.2.3 Global PTCA Coronary Drug Eluting Balloons Revenue Share by Manufacturers (2016-2021)
3.2.4 Global PTCA Coronary Drug Eluting Balloons Market Concentration Ratio (CR5 and HHI) (2016-2021)
3.2.5 Global Top 10 and Top 5 Companies by PTCA Coronary Drug Eluting Balloons Revenue in 2020
3.2.6 Global PTCA Coronary Drug Eluting Balloons Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.3 Global PTCA Coronary Drug Eluting Balloons Price by Manufacturers
3.4 Global PTCA Coronary Drug Eluting Balloons Manufacturing Base Distribution, Product Types
3.4.1 PTCA Coronary Drug Eluting Balloons Manufacturers Manufacturing Base Distribution, Headquarters
3.4.2 Manufacturers PTCA Coronary Drug Eluting Balloons Product Type
3.4.3 Date of International Manufacturers Enter into PTCA Coronary Drug Eluting Balloons Market
3.5 Manufacturers Mergers & Acquisitions, Expansion Plans
4 Breakdown Data by Type (2016-2027)
4.1 Global PTCA Coronary Drug Eluting Balloons Market Size by Type (2016-2021)
4.1.1 Global PTCA Coronary Drug Eluting Balloons Sales by Type (2016-2021)
4.1.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Type (2016-2021)
4.1.3 PTCA Coronary Drug Eluting Balloons Average Selling Price (ASP) by Type (2016-2021)
4.2 Global PTCA Coronary Drug Eluting Balloons Market Size Forecast by Type (2022-2027)
4.2.1 Global PTCA Coronary Drug Eluting Balloons Sales Forecast by Type (2022-2027)
4.2.2 Global PTCA Coronary Drug Eluting Balloons Revenue Forecast by Type (2022-2027)
4.2.3 PTCA Coronary Drug Eluting Balloons Average Selling Price (ASP) Forecast by Type (2022-2027)
5 Breakdown Data by Application (2016-2027)
5.1 Global PTCA Coronary Drug Eluting Balloons Market Size by Application (2016-2021)
5.1.1 Global PTCA Coronary Drug Eluting Balloons Sales by Application (2016-2021)
5.1.2 Global PTCA Coronary Drug Eluting Balloons Revenue by Application (2016-2021)
5.1.3 PTCA Coronary Drug Eluting Balloons Price by Application (2016-2021)
5.2 PTCA Coronary Drug Eluting Balloons Market Size Forecast by Application (2022-2027)
5.2.1 Global PTCA Coronary Drug Eluting Balloons Sales Forecast by Application (2022-2027)
5.2.2 Global PTCA Coronary Drug Eluting Balloons Revenue Forecast by Application (2022-2027)
5.2.3 Global PTCA Coronary Drug Eluting Balloons Price Forecast by Application (2022-2027)
6 United States by Players, Type and Application
6.1 United States PTCA Coronary Drug Eluting Balloons Market Size YoY Growth 2016-2027
6.1.1 United States PTCA Coronary Drug Eluting Balloons Sales YoY Growth 2016-2027
6.1.2 United States PTCA Coronary Drug Eluting Balloons Revenue YoY Growth 2016-2027
6.1.3 United States PTCA Coronary Drug Eluting Balloons Market Share in Global Market 2016-2027
6.2 United States PTCA Coronary Drug Eluting Balloons Market Size by Players (International and Local Players)
6.2.1 United States Top PTCA Coronary Drug Eluting Balloons Players by Sales (2016-2021)
6.2.2 United States Top PTCA Coronary Drug Eluting Balloons Players by Revenue (2016-2021)
6.3 United States PTCA Coronary Drug Eluting Balloons Historic Market Review by Type (2016-2021)
6.3.1 United States PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2016-2021)
6.3.2 United States PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2016-2021)
6.3.3 United States PTCA Coronary Drug Eluting Balloons Price by Type (2016-2021)
6.4 United States PTCA Coronary Drug Eluting Balloons Market Estimates and Forecasts by Type (2022-2027)
6.4.1 United States PTCA Coronary Drug Eluting Balloons Sales Forecast by Type (2022-2027)
6.4.2 United States PTCA Coronary Drug Eluting Balloons Revenue Forecast by Type (2022-2027)
6.4.3 United States PTCA Coronary Drug Eluting Balloons Price Forecast by Type (2022-2027)
6.5 United States PTCA Coronary Drug Eluting Balloons Historic Market Review by Application (2016-2021)
6.5.1 United States PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2016-2021)
6.5.2 United States PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2016-2021)
6.5.3 United States PTCA Coronary Drug Eluting Balloons Price by Application (2016-2021)
6.6 United States PTCA Coronary Drug Eluting Balloons Market Estimates and Forecasts by Application (2022-2027)
6.6.1 United States PTCA Coronary Drug Eluting Balloons Sales Forecast by Application (2022-2027)
6.6.2 United States PTCA Coronary Drug Eluting Balloons Revenue Forecast by Application (2022-2027)
6.6.3 United States PTCA Coronary Drug Eluting Balloons Price Forecast by Application (2022-2027)
7 North America
7.1 North America PTCA Coronary Drug Eluting Balloons Market Size YoY Growth 2016-2027
7.2 North America PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country
7.2.1 North America PTCA Coronary Drug Eluting Balloons Sales by Country (2016-2021)
7.2.2 North America PTCA Coronary Drug Eluting Balloons Revenue by Country (2016-2021)
7.2.3 U.S.
7.2.4 Canada
8 Asia Pacific
8.1 Asia Pacific PTCA Coronary Drug Eluting Balloons Market Size YoY Growth 2016-2027
8.2 Asia Pacific PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Region
8.2.1 Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Region (2016-2021)
8.2.2 Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region (2016-2021)
8.2.3 China
8.2.4 Japan
8.2.5 South Korea
8.2.6 India
8.2.7 Australia
8.2.8 Australia
8.2.9 Indonesia
8.2.10 Thailand
8.2.11 Malaysia
8.2.12 Philippines
8.2.13 Vietnam
9 Europe
9.1 Europe PTCA Coronary Drug Eluting Balloons Market Size YoY Growth 2016-2027
9.2 Europe PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country
9.2.1 Europe PTCA Coronary Drug Eluting Balloons Sales by Country (2016-2021)
9.2.2 Europe PTCA Coronary Drug Eluting Balloons Revenue by Country (2016-2021)
9.2.3 Germany
9.2.4 France
9.2.5 U.K.
9.2.6 Italy
10 Latin America
10.1 Latin America PTCA Coronary Drug Eluting Balloons Market Size YoY Growth 2016-2027
10.2 Latin America PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country
10.2.1 Latin America PTCA Coronary Drug Eluting Balloons Sales by Country (2016-2021)
10.2.2 Latin America PTCA Coronary Drug Eluting Balloons Revenue by Country (2016-2021)
10.2.3 Mexico
10.2.4 Brazil
10.2.5 Argentina
11 Middle East and Africa
11.1 Middle East and Africa PTCA Coronary Drug Eluting Balloons Market Size YoY Growth 2016-2027
11.2 Middle East and Africa PTCA Coronary Drug Eluting Balloons Market Facts & Figures by Country
11.2.1 Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Country (2016-2021)
11.2.2 Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country (2016-2021)
11.2.3 Turkey
11.2.4 Saudi Arabia
11.2.5 UAE
12 Company Profiles
12.1 B.Braun
12.1.1 B.Braun Corporation Information
12.1.2 B.Braun Description and Business Overview
12.1.3 B.Braun PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2016-2021)
12.1.4 B.Braun PTCA Coronary Drug Eluting Balloons Products Offered
12.1.5 B.Braun Recent Development
12.2 Spectranetics
12.2.1 Spectranetics Corporation Information
12.2.2 Spectranetics Description and Business Overview
12.2.3 Spectranetics PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2016-2021)
12.2.4 Spectranetics PTCA Coronary Drug Eluting Balloons Products Offered
12.2.5 Spectranetics Recent Development
12.3 Concept Medical
12.3.1 Concept Medical Corporation Information
12.3.2 Concept Medical Description and Business Overview
12.3.3 Concept Medical PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2016-2021)
12.3.4 Concept Medical PTCA Coronary Drug Eluting Balloons Products Offered
12.3.5 Concept Medical Recent Development
12.4 Eurocor
12.4.1 Eurocor Corporation Information
12.4.2 Eurocor Description and Business Overview
12.4.3 Eurocor PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2016-2021)
12.4.4 Eurocor PTCA Coronary Drug Eluting Balloons Products Offered
12.4.5 Eurocor Recent Development
12.5 Lifetech
12.5.1 Lifetech Corporation Information
12.5.2 Lifetech Description and Business Overview
12.5.3 Lifetech PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2016-2021)
12.5.4 Lifetech PTCA Coronary Drug Eluting Balloons Products Offered
12.5.5 Lifetech Recent Development
12.6 Maxcor
12.6.1 Maxcor Corporation Information
12.6.2 Maxcor Description and Business Overview
12.6.3 Maxcor PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2016-2021)
12.6.4 Maxcor PTCA Coronary Drug Eluting Balloons Products Offered
12.6.5 Maxcor Recent Development
12.7 Micell
12.7.1 Micell Corporation Information
12.7.2 Micell Description and Business Overview
12.7.3 Micell PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2016-2021)
12.7.4 Micell PTCA Coronary Drug Eluting Balloons Products Offered
12.7.5 Micell Recent Development
12.8 Qualimed
12.8.1 Qualimed Corporation Information
12.8.2 Qualimed Description and Business Overview
12.8.3 Qualimed PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2016-2021)
12.8.4 Qualimed PTCA Coronary Drug Eluting Balloons Products Offered
12.8.5 Qualimed Recent Development
12.9 Acrostak
12.9.1 Acrostak Corporation Information
12.9.2 Acrostak Description and Business Overview
12.9.3 Acrostak PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2016-2021)
12.9.4 Acrostak PTCA Coronary Drug Eluting Balloons Products Offered
12.9.5 Acrostak Recent Development
12.11 B.Braun
12.11.1 B.Braun Corporation Information
12.11.2 B.Braun Description and Business Overview
12.11.3 B.Braun PTCA Coronary Drug Eluting Balloons Sales, Revenue and Gross Margin (2016-2021)
12.11.4 B.Braun PTCA Coronary Drug Eluting Balloons Products Offered
12.11.5 B.Braun Recent Development
13 Market Opportunities, Challenges, Risks and Influences Factors Analysis
13.1 PTCA Coronary Drug Eluting Balloons Industry Trends
13.2 PTCA Coronary Drug Eluting Balloons Market Drivers
13.3 PTCA Coronary Drug Eluting Balloons Market Challenges
13.4 PTCA Coronary Drug Eluting Balloons Market Restraints
14 Value Chain and Sales Channels Analysis
14.1 Value Chain Analysis
14.2 PTCA Coronary Drug Eluting Balloons Customers
14.3 Sales Channels Analysis
14.3.1 Sales Channels
14.3.2 Distributors
15 Research Findings and Conclusion
16 Appendix
16.1 Research Methodology
16.1.1 Methodology/Research Approach
16.1.2 Data Source
16.2 Author Details
16.3 Disclaimer
List of Figures, Tables and Charts Available in Global and United States PTCA Coronary Drug Eluting Balloons Market Insights, Forecast to 2027
List of TablesTable 1. Global PTCA Coronary Drug Eluting Balloons Market Size Growth Rate by Type, 2016 VS 2021 VS 2027 (US$ Million)
Table 2. Major Manufacturers of DEB Balloon
Table 3. Major Manufacturers of Standard Balloon
Table 4. Global PTCA Coronary Drug Eluting Balloons Market Size Growth Rate by Application (2021-2027) & (K Units)
Table 5. Global PTCA Coronary Drug Eluting Balloons Market Size by Region (K Units) & (US$ Million), 2016 VS 2021 VS 2027
Table 6. Global PTCA Coronary Drug Eluting Balloons Sales by Regions (2016-2021) & (K Units)
Table 7. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Regions (2016-2021)
Table 8. Global PTCA Coronary Drug Eluting Balloons Revenue by Regions (2016-2021) & (US$ Million)
Table 9. Global PTCA Coronary Drug Eluting Balloons Sales Forecast by Region (2022-2027) & (K Units)
Table 10. Global PTCA Coronary Drug Eluting Balloons Sales Market Share Forecast by Region (2022-2027)
Table 11. Global PTCA Coronary Drug Eluting Balloons Revenue Forecast by Region (2022-2027) & (US$ Million)
Table 12. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share Forecast by Region (2022-2027)
Table 13. Global PTCA Coronary Drug Eluting Balloons Sales by Manufacturers (2016-2021) (K Units)
Table 14. Global PTCA Coronary Drug Eluting Balloons Sales Share by Manufacturers (2016-2021)
Table 15. Ranking of Global Top PTCA Coronary Drug Eluting Balloons Manufacturers by Revenue (US$ Million) in 2020
Table 16. PTCA Coronary Drug Eluting Balloons Revenue by Manufacturers (2016-2021) (US$ Million)
Table 17. PTCA Coronary Drug Eluting Balloons Revenue Share by Manufacturers (2016-2021)
Table 18. Global PTCA Coronary Drug Eluting Balloons Manufacturers Market Concentration Ratio (CR5 and HHI) & (2016-2021)
Table 19. Global PTCA Coronary Drug Eluting Balloons by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in PTCA Coronary Drug Eluting Balloons as of 2020)
Table 20. Key Manufacturers PTCA Coronary Drug Eluting Balloons Price (2016-2021) (USD/Unit)
Table 21. PTCA Coronary Drug Eluting Balloons Manufacturers Manufacturing Base Distribution and Headquarters
Table 22. Manufacturers PTCA Coronary Drug Eluting Balloons Product Type
Table 23. Date of International Manufacturers Enter into PTCA Coronary Drug Eluting Balloons Market
Table 24. Manufacturers Mergers & Acquisitions, Expansion Plans
Table 25. Global PTCA Coronary Drug Eluting Balloons Sales by Type (2016-2021) (K Units)
Table 26. Global PTCA Coronary Drug Eluting Balloons Sales Share by Type (2016-2021)
Table 27. Global PTCA Coronary Drug Eluting Balloons Revenue by Type (2016-2021) (US$ Million)
Table 28. Global PTCA Coronary Drug Eluting Balloons Revenue Share by Type (2016-2021)
Table 29. PTCA Coronary Drug Eluting Balloons Average Selling Price (ASP) by Type (2016-2021) & (USD/Unit)
Table 30. Global PTCA Coronary Drug Eluting Balloons Sales Forecast by Type (2022-2027) & (K Units)
Table 31. Global PTCA Coronary Drug Eluting Balloons Sales Market Share Forecast by Type (2022-2027)
Table 32. Global PTCA Coronary Drug Eluting Balloons Revenue Forecast V (2022-2027) & (US$ Million)
Table 33. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share Forecast by Type (2022-2027)
Table 34. Global PTCA Coronary Drug Eluting Balloons Average Selling Price (ASP) Forecast by Type (2022-2027) & (USD/Unit)
Table 35. Global PTCA Coronary Drug Eluting Balloons Sales by Application (2016-2021) (K Units)
Table 36. Global PTCA Coronary Drug Eluting Balloons Sales Share by Application (2016-2021)
Table 37. Global PTCA Coronary Drug Eluting Balloons Revenue by Application (2016-2021) (US$ Million)
Table 38. Global PTCA Coronary Drug Eluting Balloons Revenue Share by Application (2016-2021)
Table 39. PTCA Coronary Drug Eluting Balloons Average Selling Price (ASP) by Application (2016-2021) & (USD/Unit)
Table 40. Global PTCA Coronary Drug Eluting Balloons Sales Forecast by Application (2022-2027) & (K Units)
Table 41. Global PTCA Coronary Drug Eluting Balloons Sales Market Share Forecast by Application (2022-2027)
Table 42. Global PTCA Coronary Drug Eluting Balloons Revenue Forecast by Application (2022-2027) & (US$ Million)
Table 43. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share Forecast by Application (2022-2027)
Table 44. Global PTCA Coronary Drug Eluting Balloons Average Selling Price (ASP) Forecast by Application (2022-2027) & (USD/Unit)
Table 45. United States PTCA Coronary Drug Eluting Balloons Sales (K Units) of Key Companies (2016-2021)
Table 46. United States PTCA Coronary Drug Eluting Balloons Sales Share by Company (2016-2021)
Table 47. United States PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) by Company (2016-2021)
Table 48. United States PTCA Coronary Drug Eluting Balloons Revenue Share by Company (2016-2021)
Table 49. United States PTCA Coronary Drug Eluting Balloons Sales (K Units) by Type (2016-2021)
Table 50. United States PTCA Coronary Drug Eluting Balloons Sales Share by Type (2016-2021)
Table 51. United States PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) Market Share by Type (2016-2021)
Table 52. United States PTCA Coronary Drug Eluting Balloons Price (USD/Unit) by Type (2016-2021)
Table 53. United States PTCA Coronary Drug Eluting Balloons Sales (K Units) by Type (2022-2027)
Table 54. United States PTCA Coronary Drug Eluting Balloons Sales Share by Type (2022-2027)
Table 55. United States PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) Market Share by Type (2022-2027)
Table 56. United States PTCA Coronary Drug Eluting Balloons Revenue Share by Type (2022-2027)
Table 57. United States PTCA Coronary Drug Eluting Balloons Price (USD/Unit) by Type (2022-2027)
Table 58. United States PTCA Coronary Drug Eluting Balloons Sales (K Units) by Application (2016-2021)
Table 59. United States PTCA Coronary Drug Eluting Balloons Sales Share by Application (2016-2021)
Table 60. United States PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) Market Share by Application (2016-2021)
Table 61. United States PTCA Coronary Drug Eluting Balloons Price (USD/Unit) by Application (2016-2021)
Table 62. United States PTCA Coronary Drug Eluting Balloons Sales (K Units) by Application (2022-2027)
Table 63. United States PTCA Coronary Drug Eluting Balloons Sales Share by Application (2022-2027)
Table 64. United States PTCA Coronary Drug Eluting Balloons Revenue (US$ Million) Market Share by Application (2022-2027)
Table 65. United States PTCA Coronary Drug Eluting Balloons Revenue Share by Application (2022-2027)
Table 66. United States PTCA Coronary Drug Eluting Balloons Price (USD/Unit) by Application (2022-2027)
Table 67. North America PTCA Coronary Drug Eluting Balloons Sales by Country (2016-2021) & (K Units)
Table 68. North America PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2016-2021)
Table 69. North America PTCA Coronary Drug Eluting Balloons Revenue by Country (2016-2021) & (US$ Million)
Table 70. North America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2016-2021)
Table 71. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales by Region (2016-2021) & (K Units)
Table 72. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2016-2021)
Table 73. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue by Region (2016-2021) & (US$ Million)
Table 74. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region (2016-2021)
Table 75. Europe PTCA Coronary Drug Eluting Balloons Sales by Country (2016-2021) & (K Units)
Table 76. Europe PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2016-2021)
Table 77. Europe PTCA Coronary Drug Eluting Balloons Revenue by Country (2016-2021) & (US$ Million)
Table 78. Europe PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2016-2021)
Table 79. Latin America PTCA Coronary Drug Eluting Balloons Sales by Country (2016-2021) & (K Units)
Table 80. Latin America PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2016-2021)
Table 81. Latin Americaa PTCA Coronary Drug Eluting Balloons Revenue by Country (2016-2021) & (US$ Million)
Table 82. Latin America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2016-2021)
Table 83. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales by Country (2016-2021) & (K Units)
Table 84. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales Market Share by Country (2016-2021)
Table 85. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue by Country (2016-2021) & (US$ Million)
Table 86. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country (2016-2021)
Table 87. B.Braun Corporation Information
Table 88. B.Braun Description and Business Overview
Table 89. B.Braun PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 90. B.Braun PTCA Coronary Drug Eluting Balloons Product
Table 91. B.Braun Recent Development
Table 92. Spectranetics Corporation Information
Table 93. Spectranetics Description and Business Overview
Table 94. Spectranetics PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 95. Spectranetics Product
Table 96. Spectranetics Recent Development
Table 97. Concept Medical Corporation Information
Table 98. Concept Medical Description and Business Overview
Table 99. Concept Medical PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 100. Concept Medical Product
Table 101. Concept Medical Recent Development
Table 102. Eurocor Corporation Information
Table 103. Eurocor Description and Business Overview
Table 104. Eurocor PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 105. Eurocor Product
Table 106. Eurocor Recent Development
Table 107. Lifetech Corporation Information
Table 108. Lifetech Description and Business Overview
Table 109. Lifetech PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 110. Lifetech Product
Table 111. Lifetech Recent Development
Table 112. Maxcor Corporation Information
Table 113. Maxcor Description and Business Overview
Table 114. Maxcor PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 115. Maxcor Product
Table 116. Maxcor Recent Development
Table 117. Micell Corporation Information
Table 118. Micell Description and Business Overview
Table 119. Micell PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 120. Micell Product
Table 121. Micell Recent Development
Table 122. Qualimed Corporation Information
Table 123. Qualimed Description and Business Overview
Table 124. Qualimed PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 125. Qualimed Product
Table 126. Qualimed Recent Development
Table 127. Acrostak Corporation Information
Table 128. Acrostak Description and Business Overview
Table 129. Acrostak PTCA Coronary Drug Eluting Balloons Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2016-2021)
Table 130. Acrostak Product
Table 131. Acrostak Recent Development
Table 132. PTCA Coronary Drug Eluting Balloons Market Trends
Table 133. PTCA Coronary Drug Eluting Balloons Market Drivers
Table 134. PTCA Coronary Drug Eluting Balloons Market Challenges
Table 135. PTCA Coronary Drug Eluting Balloons Market Restraints
Table 136. PTCA Coronary Drug Eluting Balloons Customers List
Table 137. PTCA Coronary Drug Eluting Balloons Distributors List
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources
List of Figures
Figure 1. PTCA Coronary Drug Eluting Balloons Product Picture
Figure 2. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Type in 2020 & 2027
Figure 3. DEB Balloon Product Picture
Figure 4. Standard Balloon Product Picture
Figure 5. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Application in 2020 & 2027
Figure 6. Small Vessel Disease
Figure 7. Bifurcation Lesions
Figure 8. Others
Figure 9. PTCA Coronary Drug Eluting Balloons Report Years Considered
Figure 10. Global PTCA Coronary Drug Eluting Balloons Market Size, (US$ Million), 2016 VS 2021 VS 2027
Figure 11. Global PTCA Coronary Drug Eluting Balloons Market Size 2016-2027 (US$ Million)
Figure 12. Global PTCA Coronary Drug Eluting Balloons Sales 2016-2027 (K Units)
Figure 13. Global PTCA Coronary Drug Eluting Balloons Market Size Market Share by Region: 2021 Versus 2027
Figure 14. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Region (2016-2021)
Figure 15. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Region in 2020
Figure 16. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region (2016-2021)
Figure 17. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region in 2020
Figure 18. Global PTCA Coronary Drug Eluting Balloons Sales Share by Manufacturer in 2020
Figure 19. The Top 10 and 5 Players Market Share by PTCA Coronary Drug Eluting Balloons Revenue in 2020
Figure 20. PTCA Coronary Drug Eluting Balloons Market Share by Company Type (Tier 1, Tier 2 and Tier 3): 2016 VS 2020
Figure 21. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Type (2016-2021)
Figure 22. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Type in 2020
Figure 23. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type (2016-2021)
Figure 24. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Type in 2020
Figure 25. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Application (2016-2021)
Figure 26. Global PTCA Coronary Drug Eluting Balloons Sales Market Share by Application in 2020
Figure 27. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application (2016-2021)
Figure 28. Global PTCA Coronary Drug Eluting Balloons Revenue Market Share by Application in 2020
Figure 29. United States PTCA Coronary Drug Eluting Balloons Sales Growth Rate 2016-2027 (K Units)
Figure 30. United States PTCA Coronary Drug Eluting Balloons Revenue Growth Rate 2016-2027 (US$ Million)
Figure 31. United States PTCA Coronary Drug Eluting Balloons Market Share in Global Market 2016-2027
Figure 32. United States 5 and 10 Largest PTCA Coronary Drug Eluting Balloons Players Market Share by Revenue in PTCA Coronary Drug Eluting Balloons in 2020
Figure 33. United States PTCA Coronary Drug Eluting Balloons Revenue Share by Type (2016-2021)
Figure 34. United States PTCA Coronary Drug Eluting Balloons Revenue Growth Rate by Type in 2016 & 2020
Figure 35. United States PTCA Coronary Drug Eluting Balloons Revenue Share by Application (2016-2021)
Figure 36. United States PTCA Coronary Drug Eluting Balloons Revenue Growth Rate by Application in 2016 & 2020
Figure 37. North America PTCA Coronary Drug Eluting Balloons Sales Growth Rate 2016-2021 (K Units)
Figure 38. North America PTCA Coronary Drug Eluting Balloons Revenue Growth Rate 2016-2021 (US$ Million)
Figure 39. North America PTCA Coronary Drug Eluting Balloons Sales Market Share by Country in 2020
Figure 40. North America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country in 2020
Figure 41. U.S. PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 42. U.S. PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 43. Canada PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 44. Canada PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 45. Europe PTCA Coronary Drug Eluting Balloons Sales Growth Rate 2016-2021 (K Units)
Figure 46. Europe PTCA Coronary Drug Eluting Balloons Revenue Growth Rate 2016-2021 (US$ Million)
Figure 47. Europe PTCA Coronary Drug Eluting Balloons Sales Market Share by Country in 2020
Figure 48. Europe PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country in 2020
Figure 49. Germany PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 50. Germany PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 51. France PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 52. France PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 53. U.K. PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 54. U.K. PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 55. Italy PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 56. Italy PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 57. Russia PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 58. Russia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 59. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales Growth Rate 2016-2021 (K Units)
Figure 60. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue Growth Rate 2016-2021 (US$ Million)
Figure 61. Asia Pacific PTCA Coronary Drug Eluting Balloons Sales Market Share by Region in 2020
Figure 62. Asia Pacific PTCA Coronary Drug Eluting Balloons Revenue Market Share by Region in 2020
Figure 63. China PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 64. China PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 65. Japan PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 66. Japan PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 67. South Korea PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 68. South Korea PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 69. India PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 70. India PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 71. Australia PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 72. Australia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 73. Taiwan PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 74. Taiwan PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 75. Indonesia PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 76. Indonesia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 77. Thailand PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 78. Thailand PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 79. Malaysia PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 80. Malaysia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 81. Philippines PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 82. Philippines PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 83. Vietnam PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 84. Vietnam PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 85. Latin America PTCA Coronary Drug Eluting Balloons Sales Growth Rate 2016-2021 (K Units)
Figure 86. Latin America PTCA Coronary Drug Eluting Balloons Revenue Growth Rate 2016-2021 (US$ Million)
Figure 87. Latin America PTCA Coronary Drug Eluting Balloons Sales Market Share by Country in 2020
Figure 88. Latin America PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country in 2020
Figure 89. Mexico PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 90. Mexico PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 91. Brazil PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 92. Brazil PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 93. Argentina PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 94. Argentina PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 95. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales Growth Rate 2016-2021 (K Units)
Figure 96. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue Growth Rate 2016-2021 (US$ Million)
Figure 97. Middle East and Africa PTCA Coronary Drug Eluting Balloons Sales Market Share by Country in 2020
Figure 98. Middle East and Africa PTCA Coronary Drug Eluting Balloons Revenue Market Share by Country in 2020
Figure 99. Turkey PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 100. Turkey PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 101. Saudi Arabia PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 102. Saudi Arabia PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 103. UAE PTCA Coronary Drug Eluting Balloons Sales Growth Rate (2016-2021) (K Units)
Figure 104. UAE PTCA Coronary Drug Eluting Balloons Revenue Growth Rate (2016-2021) (US$ Million)
Figure 105. PTCA Coronary Drug Eluting Balloons Value Chain
Figure 106. Channels of Distribution
Figure 107. Distributors Profiles
Figure 108. Bottom-up and Top-down Approaches for This Report
Figure 109. Data Triangulation
Figure 110. Key Executives Interviewed
Keyplayers in Global and United States PTCA Coronary Drug Eluting Balloons Market Insights, Forecast to 2027
B.BraunSpectranetics
Concept Medical
Eurocor
Lifetech
Maxcor
Micell
Qualimed
Acrostak